Progressive multiple sclerosis – Life with Disease

Go back

Progressive multiple sclerosis is a form of multiple sclerosis where symptoms gradually worsen over time, affecting mobility, vision, and daily functioning. Understanding how this condition progresses and impacts life can help patients and families navigate the challenges ahead with greater confidence and support.

Understanding the Prognosis of Progressive Multiple Sclerosis

Receiving a diagnosis of progressive multiple sclerosis can feel overwhelming, especially when thinking about what the future may hold. It’s important to know that while progressive MS is a serious condition that worsens over time, each person’s experience is unique and the speed of progression varies considerably from one individual to another.

Progressive multiple sclerosis includes two main types: primary progressive multiple sclerosis, or PPMS, which affects about 10 to 15 percent of people diagnosed with MS, and secondary progressive multiple sclerosis, or SPMS, which develops in many people who initially had the relapsing-remitting form of the disease. Both types share the characteristic of gradual worsening of symptoms over time, though the starting point differs[3][5].

When it comes to life expectancy, people with multiple sclerosis generally live shorter lives compared to those without the condition, though the gap has narrowed significantly with modern treatments. Research suggests that people with MS live to an average age of about 75.9 years, compared to 83.4 years for those without the disease. Importantly, this gap was much larger just a few decades ago, reflecting the substantial improvements in diagnosis and treatment options[15].

The outlook for progressive MS depends on many factors, including how quickly symptoms develop, the age at diagnosis, and access to appropriate medical care and support. Most people with primary progressive MS receive their diagnosis between ages 40 and 50, which is about a decade later than those initially diagnosed with relapsing-remitting MS[1][4].

⚠️ Important
Progressive MS is not considered a fatal disease itself. However, people with MS are more vulnerable to complications such as heart disease, pneumonia, pressure ulcers, and urinary tract infections, which can affect overall health and longevity. The severity of these risks varies depending on how the disease progresses in each individual.

How Progressive Multiple Sclerosis Develops Without Treatment

The natural course of progressive multiple sclerosis is characterized by a steady decline in neurological function. Unlike relapsing-remitting MS, where symptoms come and go in distinct episodes, progressive MS shows a continuous pattern of worsening. In primary progressive MS, this decline begins from the very onset of symptoms, while in secondary progressive MS, it follows an earlier phase of relapses and remissions[3].

The underlying cause of this progression involves neurodegeneration, which is the gradual loss of nerve cells in the brain and spinal cord. In progressive MS, the immune system continues to attack the protective coating around nerve fibers called myelin, but the damage also extends to the nerve fibers themselves. This is different from the inflammation-driven damage seen in early relapsing-remitting disease[1][3].

Without treatment, people with progressive MS typically experience a gradual increase in walking difficulty over several years. This happens because the brain and spinal cord lose cells faster in areas damaged by MS compared to healthy areas. The rate at which this occurs varies greatly between individuals, with some experiencing relatively slow progression while others face more rapid decline[2].

The conversion from relapsing-remitting MS to secondary progressive MS occurs in approximately 70 percent of people with the relapsing form. This transition typically happens after an average of 19 years, with a conversion rate of about 2 to 3 percent per year. However, pinpointing the exact moment of conversion can be challenging because it develops slowly and may go unnoticed by both the patient and their healthcare provider for some time[3].

As progressive MS continues without intervention, the accumulation of disability becomes more pronounced. The body’s ability to repair myelin damage decreases over time, and even though some repair mechanisms exist, they become less effective. This results in the formation of permanent scars in the nervous system, which is where the name “multiple sclerosis” originates—referring to multiple areas of scarring[2].

Possible Complications and Unfavorable Developments

Progressive multiple sclerosis can lead to various complications that significantly affect quality of life and overall health. These complications arise from the ongoing damage to the nervous system and the body’s decreasing ability to perform normal functions.

One of the most common complications is spasticity, which refers to severe muscle tightness and stiffness. This can make movement painful and difficult, affecting the ability to walk, reach for objects, or perform simple daily tasks. Muscle weakness often accompanies spasticity, creating additional challenges for maintaining mobility and independence[1][4].

Vision problems represent another significant complication. Progressive MS can cause vision loss, double vision, or damage to the optic nerve. These visual impairments can make reading, driving, and recognizing faces difficult, fundamentally changing how someone interacts with their environment[1][4].

Bladder and bowel control difficulties are particularly distressing complications. Many people with progressive MS experience urgency, frequency, or difficulty urinating, as well as problems controlling bowel movements. These issues can lead to embarrassing situations and significantly limit social activities. Bladder problems also increase the risk of urinary tract infections, which can cause additional health concerns[1][4].

Sexual dysfunction affects many people with progressive MS, impacting intimate relationships and emotional wellbeing. This can include reduced sensation, difficulty achieving arousal, or physical limitations that make sexual activity challenging. These issues are often difficult to discuss but represent an important aspect of overall quality of life[1][4].

Cognitive changes pose serious challenges as progressive MS advances. People may experience difficulty with memory, learning new information, processing information quickly, or maintaining concentration. These cognitive problems can affect work performance, relationships, and the ability to manage daily responsibilities independently. Some people also experience mood changes, including depression, which can be both a direct result of brain changes and an emotional response to living with chronic disability[1][4].

Impact on Daily Life and Activities

Living with progressive multiple sclerosis profoundly affects nearly every aspect of daily life. The gradual worsening of symptoms means that tasks that were once simple become increasingly challenging, requiring adaptation, assistance, and often, significant lifestyle changes.

Physical activities are among the first areas affected. Walking becomes progressively more difficult, with many people experiencing trouble with coordination, balance, and stamina. Simple actions like climbing stairs, standing for extended periods, or walking long distances may become impossible without assistive devices. Some people eventually require canes, walkers, or wheelchairs to maintain mobility. This physical decline can make grocery shopping, cooking, cleaning, and other household tasks exhausting or unmanageable without help[4][13].

Work life often requires significant adjustments or may become impossible to continue. The combination of physical limitations, fatigue, and cognitive difficulties can make maintaining employment challenging. Some people can continue working with accommodations such as flexible schedules, modified duties, or the ability to work from home. However, others find that progressive MS forces early retirement, bringing financial stress and loss of professional identity[16].

Fatigue is an especially difficult symptom that affects daily functioning in ways that others may not understand. Unlike ordinary tiredness, MS-related fatigue is overwhelming and doesn’t necessarily improve with rest. It can strike suddenly and make even simple activities feel impossible. This unpredictable exhaustion can interfere with work, social plans, and family responsibilities, making it difficult to maintain commitments or participate in activities[4][17].

Social relationships and recreational activities face challenges as progressive MS advances. Hobbies that require physical activity, fine motor skills, or stamina may need to be abandoned or significantly modified. Social gatherings can become difficult due to fatigue, mobility limitations, or bladder control concerns. Some people find themselves becoming increasingly isolated as participating in activities becomes more challenging[13][16].

The emotional and mental health impact of progressive MS cannot be overlooked. Many people experience depression, anxiety, or frustration as they cope with increasing disability and loss of independence. The stress of an uncertain future, combined with the daily challenges of managing symptoms, takes a significant toll on mental wellbeing. Some people describe feeling as though their dreams and life plans have been stolen, particularly when diagnosed at a young age[13][15].

⚠️ Important
Despite these challenges, many people with progressive MS find ways to adapt and maintain quality of life. Regular exercise appropriate to your abilities, a nutritious diet, adequate rest, stress management techniques, and strong support systems can all help manage symptoms and improve daily functioning. Mental health support through counseling or therapy is equally important as physical treatments.

Supporting Family Members Through Clinical Trials

For families dealing with progressive multiple sclerosis, understanding clinical trials represents an important aspect of exploring all available options. Clinical trials test new treatments, therapies, or approaches to managing MS, and participation can provide access to cutting-edge interventions not yet widely available.

Family members should understand that clinical trials for progressive MS face unique challenges. The slow, gradual progression of symptoms makes it difficult to measure whether a treatment is working, as changes may take months or years to become apparent. Additionally, the underlying causes of progressive MS differ from relapsing-remitting MS, involving more neurodegeneration and less inflammation, which means treatments that work for one type may not work for the other[11].

Historically, many clinical trials for progressive MS have had disappointing results, which reflects the complexity of the condition and the challenges in developing effective treatments. However, ongoing research continues to explore both medications that modify the immune system and therapies designed to protect nerve cells from damage. Understanding that finding effective treatments for progressive MS remains an active area of research can help families maintain realistic expectations while staying hopeful[11].

Families can support their loved one in finding and preparing for clinical trial participation in several ways. First, help research available trials through reputable sources and discuss options with the patient’s neurologist. Healthcare providers can offer valuable insights into which trials might be appropriate and what to expect. Keep organized records of all medical information, as clinical trials typically require detailed medical histories and documentation[11].

When a family member is considering a clinical trial, provide practical support by helping with transportation to appointments, organizing medication schedules if the trial involves investigational drugs, and attending medical visits to help remember information and ask questions. Emotional support is equally crucial, as participating in a trial can be stressful and may involve additional testing, more frequent medical appointments, and uncertainty about whether receiving an active treatment or a placebo.

Family members should also help their loved one understand the commitments involved in trial participation, including the duration of the study, frequency of visits, potential side effects, and what happens after the trial ends. Discuss together whether the time commitment and requirements are manageable given current life circumstances and other health needs.

It’s important for families to recognize that participating in a clinical trial is a personal decision that the patient should make based on their own values, goals, and circumstances. The role of family is to support, inform, and assist rather than to pressure or decide. Some people find meaning in contributing to research that may help others in the future, even if they don’t personally benefit, while others prefer to focus on currently available treatments.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Ocrelizumab (Ocrevus) – The only FDA-approved medication specifically for slowing the progression of primary progressive multiple sclerosis
  • Ocrevus Zunovo – A subcutaneous formulation of ocrelizumab that provides twice-yearly under-the-skin dosing as an alternative treatment delivery option for MS

Ongoing Clinical Trials on Progressive multiple sclerosis

  • A study testing ACT-1004-1239 compared to placebo for adults with progressive multiple sclerosis to measure nerve repair using MRI scans

    Recruiting

    Investigated diseases:
    Investigated drugs:
    The Netherlands
  • Study on the Effects of Siponimod for Patients with Secondary Progressive Multiple Sclerosis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy
  • Study on Human Fetal Neural Precursor Cells and Tacrolimus for Patients with Progressive Multiple Sclerosis

    Recruiting

    1 1 1
    Investigated diseases:
    Italy
  • Study on the Effects of Vidofludimus Calcium (IMU-838) in Patients with Progressive Multiple Sclerosis

    Recruiting

    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Germany The Netherlands Poland Romania
  • Study on the Effects of Siponimod on Imaging and Immune Markers in Patients with Progressive Multiple Sclerosis

    Recruiting

    1 1 1 1
    Investigated diseases:
    Italy
  • Study on Istradefylline for Reducing Brain Inflammation in Patients with Progressive Multiple Sclerosis

    Recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Finland
  • A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

    Not yet recruiting

    1 1
    Investigated drugs:
    Finland
  • Study of KYV-101 Therapy for Patients with Refractory Primary and Secondary Progressive Multiple Sclerosis

    Not yet recruiting

    1 1 1
    Austria Belgium Germany Italy
  • Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

    Not recruiting

    1 1 1 1
    Czechia Denmark France Germany Italy The Netherlands +1
  • Study on Metformin for Delaying Progression in Non-Active Progressive Multiple Sclerosis Patients

    Not recruiting

    1 1
    Belgium

References

https://my.clevelandclinic.org/health/diseases/14202-primary-progressive-multiple-sclerosis-ppms

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269

https://pmc.ncbi.nlm.nih.gov/articles/PMC3001222/

https://www.cedars-sinai.org/health-library/diseases-and-conditions/p/–primary-progressive-multiple-sclerosis-ppms.html

https://mstrust.org.uk/a-z/primary-progressive-ms

https://www.ummhealth.org/health-library/primary-progressive-multiple-sclerosis

https://www.uhhospitals.org/health-information/health-and-wellness-library/article/diseases-and-conditions/primary-progressive-multiple-sclerosis

https://pmc.ncbi.nlm.nih.gov/articles/PMC10092602/

https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/diagnosis-treatment/drc-20350274

https://my.clevelandclinic.org/health/diseases/14202-primary-progressive-multiple-sclerosis-ppms

https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/emerging-therapies-for-progressive-multiple-sclerosis/30125/

https://www.cedars-sinai.org/health-library/diseases-and-conditions/p/progressive-relapsing-ms-prms.html

https://www.everydayhealth.com/multiple-sclerosis/tips-for-coping-with-a-diagnosis-of-primary-progressive-multiple-sclerosis-ppms/

https://my.clevelandclinic.org/health/diseases/17248-multiple-sclerosis

https://www.houstonmethodist.org/blog/articles/2025/mar/living-well-with-ms-how-to-slow-progression-reduce-symptoms-of-multiple-sclerosis/

https://www.webmd.com/multiple-sclerosis/living-with-multiple-sclerosis

https://ameripharmaspecialty.com/multiple-sclerosis/10-tips-for-living-with-multiple-sclerosis/

https://www.healthline.com/multiple-sclerosis/living-with-ms

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

What is the difference between primary progressive and secondary progressive MS?

Primary progressive MS shows gradual worsening of symptoms from the very beginning of the disease, with few or no relapses. Secondary progressive MS begins as relapsing-remitting MS with distinct episodes of symptoms followed by recovery, but then transitions to steady worsening over time. Both share the characteristic of progressive disability, but they differ in their starting point.

How quickly does progressive multiple sclerosis worsen?

The rate of progression varies greatly between individuals. Some people experience relatively slow, gradual changes over many years, while others face more rapid decline. There can also be periods when symptoms remain stable or even show minor temporary improvement. The speed of progression cannot be accurately predicted for any individual person.

What percentage of MS patients have the progressive form?

About 10-15% of people diagnosed with MS have primary progressive MS from the beginning. Additionally, approximately 70% of people who initially have relapsing-remitting MS eventually develop secondary progressive MS, typically after about 19 years with the relapsing form.

Can progressive MS be stopped or reversed?

Currently, there is no cure for progressive MS and damage cannot be reversed. However, treatments can help slow the progression of the disease. Only one medication, ocrelizumab (Ocrevus), has been approved specifically for slowing primary progressive MS. Various treatments are also available to manage individual symptoms and improve quality of life.

At what age is progressive MS typically diagnosed?

Primary progressive MS is typically diagnosed when people are in their 40s or 50s, about a decade later than relapsing-remitting MS which usually appears before age 40. Secondary progressive MS typically develops in people who have had relapsing-remitting MS for an average of 19 years.

🎯 Key takeaways

  • Progressive MS shows continuous worsening rather than the relapses and remissions seen in relapsing-remitting MS
  • Only 10-15% of people have primary progressive MS from the start, but 70% with relapsing MS eventually develop secondary progressive MS
  • People with MS live to an average age of about 76 years, and this gap with the general population has narrowed significantly with modern treatments
  • The underlying cause of progression involves neurodegeneration—actual loss of nerve cells—not just inflammation
  • Complications can include muscle spasticity, vision loss, bladder problems, sexual dysfunction, and cognitive difficulties
  • Fatigue in MS is uniquely overwhelming and unpredictable, different from ordinary tiredness
  • Disease-modifying therapies can prevent new lesions in 99% of MS patients when treatment is started early
  • Exercise, proper nutrition, adequate rest, and mental health support all contribute to managing progressive MS effectively